Abbott Laboratories

Return on Assets, %

7.8

-11.9

Net income margin, %

15.5

-12.5

EBITDA margin, %

26.7

-2.5

Debt to Equity, %

38

15

Intangible assets and goodwill, %

44.3

3.9

Revenue CAGR 3Y, %

5

12.6

Total Equity change 1Y, %

5.2

0

Revenue Y, % chg

-8.2

4.6

P/E

33.3

28.3

P/BV

4.9

1.7

P/S

4.7

3.7

EV/S

4.9

3.2

EV/EBITDA

19.7

-0.2

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

17.3

66.5

Forward P/E

23

19.2

Dividend Yield, %

2

1.8

Forward Dividend Yield, %

1.9

0.2

Expected dividend per share

2.1

0

Payout Ratio, %

63.3

17.3

Dividend Ex Date

2024-04-12